Saturday 17 November 2018
Home      All news      Contact us      Philipino
Channel News Asia - 25 days ago

AstraZeneca digs deeper into cancer with Innate stake

British drugmaker AstraZeneca will buy a newly-issued equity stake of 9.8 percent in smaller French peer Innate Pharma, strengthening its presence in the field of immuno-oncology.

Related news

Latest News
Hashtags:   

AstraZeneca

 | 

deeper

 | 

cancer

 | 

Innate

 | 

stake

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources